| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.0078 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.0071 | 1 |